Funder
Government of Japan Ministry of Health Labour and Welfare
Kowa Company Ltd
Reference28 articles.
1. Japanese Nationwide PCI (J-PCI) Registry Annual Report 2019: patient demographics and in-hospital outcomes;Ando;Cardiovasc. Interv. Ther.,2022
2. Adetola Olaniyi Bojuwoye, Fatima Suleman, Velisha Ann Perumal-Pillay. Polypharmacy and the occurrence of potential drug-drug interactions among geriatric patients at the outpatient pharmacy department of a regional hospital in Durban, South Africa. J Pharm Policy Pract 2022;15(1):1. doi: 10.1186/s40545-021-00401-z.
3. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects;Lynch;Am. Fam. Physician,2007
4. Basic concepts and resolution for polypharmacy;Kojima;Nihon Ronen Igakkai Zasshi.,2019
5. Prevalence, associated factors, and misuse of medication in the elderly: a review;Rozenfeld;Cad. Saude Publica,2003